Hydroxycarbamide in combination with azacitidine or decitabine is antagonistic on DNA methylation inhibition
The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Abstract
Summary: Azacitidine and decitabine are cytidine analogues that inhibit DNA methylation, and are used to treat myeloid haematological malignancies. Hydroxycarbamide (HC) (also known as hydroxyurea), a ribonucleotide reductase (RR) inhibitor, blocks the conversion of ribonucleotides to deoxyribonucleotides, and is also used to treat leukaemia and sickle‐cell disease. Azacitidine is a ribonucleoside and decitabine is a deoxyribonucleoside; therefore, we hypothesized that inhibition of RR by HC would be antagonistic to azacitidine and synergistic to decitabine. HL‐60 and T24 cancer cell lines were treated with azacitidine or decitabine in combination with HC and DNA methylation of LRE1, MAGEA1 and CDKN2A was quantitatively measured by bisulphite‐polymerase chain reaction pyrosequencing. Surprisingly, we found that HC blocked the ability of both azacitidine and decitabine to inhibit DNA methylation and this antagonistic effect was attributable to the arrest of the cell cycle induced by HC. However, this antagonism could be avoided with sequential treatment of HC followed by azacitidine or decitabine. This data suggest that concurrent combination of HC blocks the ability of azacitidine and decitabine to inhibit DNA methylation and therefore these drugs should be used sequentially.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cellular differentiation, cytidine analogs and DNA methylation
Jones, P. A., & Taylor, S. M. (1980) · Cell · doi:10.1016/0092-8674(80)90237-8 · Cited by 1,831 · cited 1×
“This is consistent with previous work, which showed lower doses of the drug to be more effective in inhibiting DNA methylation (Jones & Taylor, 1980).”
ResultA simple method for estimating global DNA methylation using bisulfite PCR of repetitive DNA elements
Yang, A. S. (2004) · Nucleic Acids Research · doi:10.1093/nar/gnh032 · Cited by 1,033
Self-citation5-Azacytidine stimulates fetal hemoglobin synthesis in anemic baboons.
DeSimone, J., Heller, P., Hall, L., & Zwiers, D. (1982) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.79.14.4428 · Cited by 384 · cited 4×
“When HC was administered 30 min prior to azacitidine, stimulation of fetal haemoglobin production was decreased by at least 70%, compared with azacitidine alone (De Simone et al, 1982).”
BackgroundResultInfluentialSaunthararajah, Y., Hillery, C. A., Lavelle, D., Molokie, R., Dorn, L., Bressler, L., Gavazova, S., Chen, Y.-H., Hoffman, R., & DeSimone, J. (2003) · Blood · doi:10.1182/blood-2003-05-1738 · Cited by 277 · cited 3×
“…decitabine, hydroxycarbamide, myelodysplastic syndromes, DNA methylation. research paper ª 2007 The Authors doi:10.1111/j.1365-2141.2007.06707.x Journal Compilation ª 2007 Blackwell Publishing Ltd, British Journal of Haematology, 138, 616–623 (De Simone et al, 1982; Saunthararajah et al, 2003).”
BackgroundInfluential
Cited by
Modes of action of the DNA methyltransferase inhibitors azacytidine and decitabine
Stresemann, C., & Lyko, F. (2008) · International Journal of Cancer · doi:10.1002/ijc.23607 · Cited by 949
Rapid DNA methylation changes after exposure to traffic particles
Baccarelli, A., Wright, R. O., Bollati, V., Tarantini, L., Litonjua, A. A., Suh, H. H., Zanobetti, A., Sparrow, D., Vokonas, P. S., & Schwartz, J. (2009) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200807-1097oc · Cited by 653
“In patients with myeloid leukemia treated with the demethylating analog 5-Aza-29-deoxycytidine, LINE-1 methylation has been shown to decrease starting 2 to 4 days after the beginning of the treatment (32).”
BackgroundPrenatal Tobacco Smoke Exposure Affects Global and Gene-specific DNA Methylation
Breton, C. V., Byun, H.-M., Wenten, M., Pan, F., Yang, A., & Gilliland, F. D. (2009) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200901-0135oc · Cited by 596
Self-citationFandy, T. E., Herman, J. G., Kerns, P., Jiemjit, A., Sugar, E. A., Choi, S.-H., Yang, A. S., Aucott, T., Dauses, T., Odchimar-Reissig, R., et al. (2009) · Blood · doi:10.1182/blood-2009-02-203547 · Cited by 282
Self-citationEpigenetic cancer therapy: rationales, targets and drugs
Rius, M., & Lyko, F. (2012) · Oncogene · doi:10.1038/onc.2011.601 · Cited by 157
Metadata
- Authors
- Choi, S. H., Byun, H., Kwan, J. M., Issa, J. J., & Yang, A. S.
- Venue
- British Journal of Haematology
- Publisher
- Wiley
- Published
- 2007-08-02
- Volume
- 138
- Issue
- 5
- Pages
- 616-623
- ISSN
- 0007-1048 (ISSN-L)
- 1365-2141
- OpenAlex
- W2037630216
- Cited by
- 38
- References
- 4
- FWCI
- 1.80
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Hydroxycarbamide in combination with azacitidine or decitabine is antagonistic on DNA methylation inhibition. https://app.cochat.ai/papers/10.1111/j.1365-2141.2007.06707.x
- The paper
- Choi, S. H., Byun, H., Kwan, J. M., Issa, J. J., & Yang, A. S. (2007). Hydroxycarbamide in combination with azacitidine or decitabine is antagonistic on DNA methylation inhibition. British Journal of Haematology. https://doi.org/10.1111/j.1365-2141.2007.06707.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.